Solstice Oncology Secures $225 Million in Series A Financing for Innovative Cancer Treatment Development #USA #Cambridge #Harbour_BioMed #Porustobart #Solstice_Oncology
@newsen.bsky.social
@newsen.bsky.socialSolstice Oncology Secures $225 Million in Series A Financing for Innovative Cancer Treatment Development #USA #Cambridge #Harbour_BioMed #Porustobart #Solstice_Oncology
@newsen.bsky.socialHBM9378/WIN378: A New Hope for Asthma Patients in Phase 3 Trials #USA #Cambridge #HBM9378 #Harbour_BioMed #asthma
@newsen.bsky.socialHarbour BioMed's Inclusion in Stock Connect Marks a New Era of Recognition in Capital Markets #China #Shanghai #biopharmaceuticals #Harbour_BioMed #Stock_Connect